This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Vectura Gmbh. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Raimund Johannes Gleixner: Innovator in Inhalation Device Technology
Introduction
Raimund Johannes Gleixner is a notable inventor based in Munich, Germany. He has made significant contributions to the field of inhalation devices, particularly through his innovative dosing system. His work is characterized by a commitment to precision and efficiency in medical technology.
Latest Patents
Gleixner holds a patent for a dosing system designed for an inhalation device. This invention is capable of aliquoting a precise and accurately metered volume from a larger pre-defined fill volume. The dosing system includes a filling chamber for receiving a liquid to be aerosolized, featuring a lateral wall, an inlet opening, and an outlet opening with a closing means for sealing the outlet. Additionally, it comprises an overflow chamber surrounding the inlet opening and a plunger that can be inserted into the filling chamber. This plunger sealingly contacts the lateral wall, allowing it to displace liquid from the filling chamber and push a metered volume of the liquid through the outlet opening to the nebulizing means of the inhalation device.
Career Highlights
Gleixner is currently associated with Vectura GmbH, where he continues to develop innovative solutions in inhalation technology. His work has been instrumental in advancing the capabilities of inhalation devices, making them more effective for users.
Collaborations
He collaborates with talented professionals in his field, including Monika Hartmann and Martin Christoph Heiss. Their combined expertise contributes to the success of their projects and innovations.
Conclusion
Raimund Johannes Gleixner is a key figure in the development of inhalation devices, with a focus on precision dosing systems. His contributions to the field are significant and continue to impact medical technology positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile